# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
MediPharm Labs (OTC:MEDIF) reported quarterly losses of $(0.01) per share. This is a 40 percent increase over losses of $(0.01)...
MediPharm Labs (OTC:MEDIF) reported $8.531 million in sales this quarter. This is a 12.77 percent increase over sales of $7.565...
Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's...
MediPharm Labs (OTC:MEDIF) reported quarterly sales of $7.53 million which missed the analyst consensus estimate of $10.54 mill...
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry trans...
MediPharm Labs (OTC:MEDIF) will report on Q4 2024.
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third qua...
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday f...
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, w...